Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Shareholders??? Deficit (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes In Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 116,750 $ 37,266,328 $ (40,000,015) $ (2,616,937)
Balance (in Shares) at Dec. 31, 2019 116,749,633
Shares issued for conversion of accounts payable $ 151 5,907 6,058
Shares issued for conversion of accounts payable (in Shares) 151,456
Common shares issued for cash $ 7,000 273,000 280,000
Common shares issued for cash (in Shares) 7,000,000
Common shares issued for conversion of accrued interest $ 475 12,245 12,720
Common shares issued for conversion of accrued interest (in Shares) 475,000
Common shares issued for services $ 1,250 48,750 50,000
Common shares issued for services (in Shares) 1,250,000
Issuance of warrants in connection with convertible debt 8,676 8,676
Accretion of stock-based compensation 170,072 170,072
Accretion of stock option expense 191,308 191,308
Net loss (1,508,288) (1,508,288)
Balance at Mar. 31, 2020 $ 125,626 37,976,286 (41,508,303) (3,406,391)
Balance (in Shares) at Mar. 31, 2020 125,626,089
Balance at Dec. 31, 2020 $ 228,347 42,573,272 (45,968,839) (3,167,220)
Balance (in Shares) at Dec. 31, 2020 228,346,974
Common shares issued for stock-based compensation $ 2,700 (2,700)
Common shares issued for stock-based compensation (in Shares) 2,700,000
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 3,778,810 3,778,810
Common shares issued for accrued compensation $ 945 54,796 55,741
Common shares issued for accrued compensation (in Shares) 944,767
Accretion of stock-based compensation 108,554 108,554
Accretion of stock-based professional fees 5,000 5,000
Common shares issued for professional fees $ 1,550 112,550 114,100
Common shares issued for professional fees (in Shares) 1,550,000
Common shares issued for cashless warrant exercise $ 1,008 (1,008)
Common shares issued for cashless warrant exercise (in Shares) 1,008,000
Preferred stock dividends and deemed dividend 2,845,238 (2,855,576) (10,338)
Net loss (4,863,973) (4,863,973)
Balance at Mar. 31, 2021 $ 234,550 $ 49,474,512 $ (53,688,388) $ (3,979,326)
Balance (in Shares) at Mar. 31, 2021 234,549,741